Researchers call for fix to pharmacy‐level barriers to buprenorphine

Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2024-12-13
DOI
https://doi.org/10.1002/adaw.34350
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Researchers call for fix to pharmacy‐level barriers to buprenorphine

Gary A. Enos
Alcoholism & Drug Abuse Weekly
Opioid Use Disorder Treatment
article

Researchers call for fix to pharmacy‐level barriers to buprenorphine

Gary A. Enos
article en

Abstract

Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.

Alcoholism & Drug Abuse WeeklyVol. 36(47)
Openalex Percentile: Top 65%
Opioid Use Disorder Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Researchers call for fix to pharmacy‐level barriers to buprenorphine — Gary A. Enos · Alcoholism & Drug Abuse Weekly (2024) | TGRS Research Map | TGRS